Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model-Reference-Cited by-同舟云学术

Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model

Published:2017-10-04 Issue:1 Volume:7 Page:e1378843
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Bocca Paola¹,Di Carlo Emma²³,Caruana Ignazio⁴^ORCID,Emionite Laura⁵^ORCID,Cilli Michele⁵,De Angelis Biagio⁴^ORCID,Quintarelli Concetta⁴⁶,Pezzolo Annalisa¹,Raffaghello Lizzia¹,Morandi Fabio¹^ORCID,Locatelli Franco⁴⁷,Pistoia Vito⁸,Prigione Ignazia¹

Affiliation:

1. Laboratory of Oncology, Dep. of Translational Research, IRCCS Istituto G. Gaslini, Genova, Italy

2. Anatomic Pathology and Molecular Medicine, Dep. of Medicine and Sciences of Aging, “G. d'Annunzio” University, Chieti, Italy

3. Ce. S. I.-MeT, Aging Research Center, Pathological Anatomy and Immuno-Oncology Unit, “G. d'Annunzio” University, Chieti, Italy

4. Laboratory of Cell and Gene Therapy of Pediatric Tumors, Dep. of Hematology/Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy

5. S.S.D. Animal Facility, Ospedale Policlinico San Martino, IRCCS per l'Oncologia, Genova, Italy

6. Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy

7. Department of Pediatrics, Università di Pavia, Pavia, Italy

8. Immunology Area, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1378843

Reference56 articles.

1. Neuroblastoma: developmental biology, cancer genomics and immunotherapy

2. Recent Advances in Neuroblastoma

3. Immunology and immunotherapy of neuroblastoma

4. Engineered T cells for anti-cancer therapy

5. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights;Frontiers in Immunology;2024-09-05

2. Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment;eBioMedicine;2024-08

4. CAR-T cell technologies that interact with the tumour microenvironment in solid tumours;Expert Review of Clinical Immunology;2024-07-17

5. Neuroblastoma—A Review of Combination Immunotherapy;International Journal of Molecular Sciences;2024-07-15